000 | 01981 a2200565 4500 | ||
---|---|---|---|
005 | 20250515005908.0 | ||
264 | 0 | _c20060103 | |
008 | 200601s 0 0 eng d | ||
022 | _a0002-9149 | ||
024 | 7 |
_a10.1016/j.amjcard.2005.07.061 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCarr, Albert A | |
245 | 0 | 0 |
_aHospitalizations for new heart failure among subjects with diabetes mellitus in the RENAAL and LIFE studies. _h[electronic resource] |
260 |
_bThe American journal of cardiology _cDec 2005 |
||
300 |
_a1530-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xtherapeutic use |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAngiotensin II Type 1 Receptor Blockers _xtherapeutic use |
650 | 0 | 4 |
_aAtenolol _xtherapeutic use |
650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xcomplications |
650 | 0 | 4 |
_aDiabetic Nephropathies _xcomplications |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aHeart Failure _xcomplications |
650 | 0 | 4 | _aHospitalization |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypertension _xcomplications |
650 | 0 | 4 |
_aLosartan _xtherapeutic use |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aKowey, Peter R | |
700 | 1 | _aDevereux, Richard B | |
700 | 1 | _aBrenner, Barry M | |
700 | 1 | _aDahlöf, Björn | |
700 | 1 | _aIbsen, Hans | |
700 | 1 | _aLindholm, Lars H | |
700 | 1 | _aLyle, Paulette A | |
700 | 1 | _aSnapinn, Steven M | |
700 | 1 | _aZhang, Zhongxin | |
700 | 1 | _aEdelman, Jonathan M | |
700 | 1 | _aShahinfar, Shahnaz | |
773 | 0 |
_tThe American journal of cardiology _gvol. 96 _gno. 11 _gp. 1530-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.amjcard.2005.07.061 _zAvailable from publisher's website |
999 |
_c15933438 _d15933438 |